Bristol Myers Squibb has received two expanded U.S. approvals for Opdivo (nivolumab) combinations that establish additional immunotherapy options for classical Hodgkin lymphoma across pediatric and adult populations. The FDA approved Opdivo in combination with doxorubicin, vinblastine and dacarbazine (AVD) for…
Pharmacy
The Institute for Safe Medication Practices outlined 15 strategies for reducing medication errors in clinical settings in its 2026-2027 “Targeted Medication Safety Best Practices for Hospitals.” The update includes three new best practices and 12 carried forward from previous cycles.…
The FDA will hold a public hearing June 12 to gather feedback on its Commissioner’s National Priority Voucher pilot program. The hearing will be held at the agency’s White Oak campus in Silver Spring, Md., with options to attend virtually,…
CSL, a global biotechnology company, is experiencing a temporary worldwide stockout of Hemgenix (etranacogene dezaparvovec-drlb), its one-time gene therapy for adults with hemophilia B. The shortage will delay treatment for some patients in countries where the therapy is commercially available,…
Kenny Yu, PharmD, has been named senior vice president and chief pharmacy officer at New York City-based Mount Sinai Health System, according to a March 21 LinkedIn post. Dr. Yu joins the system from NYU Langone Health, where he spent…
Advertisement
The federal direct-to-consumer website TrumpRx.gov currently lists 54 brand-name medications accessible through manufacturer-run cash discount programs. That number is expected to grow, as the White House plans to add three additional therapies from Boehringer Ingelheim, according to a March 20…
Artificial intelligence is gaining traction across hospital pharmacy operations, but many health systems struggle to move beyond small pilot programs. According to Bickkie Solomon, PharmD, director of pharmacy at HCA Florida North Florida Hospital, part of Nashville, Tenn.-based HCA Healthcare,…
The American Society of Health-System Pharmacists has appointed Samuel Calabrese as executive vice president and CEO, effective May 1. Mr. Calabrese will become the fifth CEO in the organization’s 84-year history, succeeding Paul Abramowitz, PharmD, who retired earlier this year,…
A federal appeals court has revived a whistleblower lawsuit alleging four drugmakers overcharged for medications under the 340B program. In a 3-0 decision, the 9th U.S. Circuit Court of Appeals ruled that AbbVie, AstraZeneca, Novartis and Sanofi must face claims…
Charlottesville, Va.-based UVA Health has opened a central pharmacy facility to support its expanding specialty and home delivery pharmacy services. The 40,000-square-foot center, located in North Fork, Va., features an automation system designed to process up to 4,000 prescriptions per…